Ibudilast reduces intracellular calcium elevation induced by in vitro ischaemia in gerbil hippocampal slices

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 4, 1996, Pages 317-324

  Yanase, Hisato ^a   Mitani, Akira ^a   Kataoka, Kiyoshi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

calcium; hippocampus; ibudilast; ischaemia; microfluorometry; neurons

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM ANTAGONIST; DANTROLENE; DIZOCILPINE; FLUNARIZINE; IBUDILAST; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; NIFEDIPINE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; ISCHEMIA; MALE; NONHUMAN;

EID: 0029954741     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02830.x     Document Type: Article

References (45)

1. Benveniste H, Jørgensen MB, Diemer NH, Hansen AJ. Calcium accumulation by glutamate receptor activation is involved in hippocampal cell damage after ischemia. Acta Neurol. Scand. 1988; 78: 529-36.
2. Deleo J, Toth L, Schubert P, Rudolphi K, Kreutzberg GW. Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285). J. Cereb. Blood Flow Metab. 1987; 7: 745-51.
3. Deshpande JK, Siesjö BK, Wieloch T. Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J. Cereb. Blood Flow Metab. 1987; 7: 89-95.
4. Schanne FAX, Kane A, Young EE, Farber J. Calcium dependence of toxic death: A final common pathway. Science 1979; 206: 700-2.
5. Siesjö BK, Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J. Cereb. Blood Flow Metab. 1989; 9: 127-40.
6. Simon RP, Griffiths T, Evans MC, Swan JH, Meldrum BS. Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: An electron microscopy study in the rat. J. Cereb. Blood Flow Metab. 1984; 4: 350-61.
7. Mitani A, Kadoya F, Kataoka K. Temperature dependence of hypoxia-induced calcium accumulation in gerbil hippocampal slices. Brain Res. 1991; 562: 159-63.
8. Brierley JB. Cerebral hypoxia. In: Blackwood W, Corsellis JAN (eds). Greenfield's Neuropathology, 3rd edn. Edward Arnold, London. 1976; 41-85.
9. Ito U, Spatz M, Walker JT Jr, Klatzo I. Experimental cerebral ischemia in Mongolian gerbils. I. Light microscopic observations. Acta Neuropathol. 1975; 32: 209-23.
10. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982; 237: 57-69.
11. Kirino T, Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. 1984; 62: 201-8.
12. Pulsinelli W. Selective neuronal vulnerability: Morphological and molecular characteristics. Prog. Brain Res. 1985; 63: 29-37.
13. Pulsinelli W, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 1982; 11: 491-8.
14. 4-induced contractile responses in isolated guinea-pig smooth muscles. Prostaglandins 1986; 32: 875-88.
15. 4 receptors. Mol. Pharmacol. 1987; 31: 35-41.
16. I) and evidence that leukotriene induced contraction in these cells is mediated by thromboxane, protein and RNA synthesis. Eur. J. Pharmacol. 1985; 116: 207-20.
17. 4 receptor-mediated hydrolysis of phosphoinositide and mobilization of calcium in sheep tracheal smooth muscle cells. J. Pharmacol. Exp. Ther. 1988; 244: 508-15.
18. 4-induced formation of inositol phosphates in guinea-pig lung. Br. J. Pharmacol. 1990; 100: 564-8.
19. Ohashi M, Kito J, Nishino K. Mode of cerebral vasodilating action of KC-404 in isolated canine basilar artery. Arch. Int. Pharmacodyn. 1986; 280: 216-29.
20. Ohashi M, Kudo Y, Ichikawa Y, Nishino K. Anti-thrombotic effect of KC-404, a novel cerebral vasodilator. Gen. Pharmacol. 1986; 17: 385-9.
21. 2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res. 1993; 601: 103-10.
22. Minta A, Kao JPY, Tsien RY. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem. 1989; 264: 8171-8.
23. Kudo Y, Nakamura T, Ito E. A 'macro' image analysis of fura-2 fluorescence to visualize the distribution of functional glutamate receptor subtypes in hippocampal slice. Neurosci. Res. 1991; 12: 412-20.
24. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529-31.
25. Kadoya F, Mitani A, Arai T, Kataoka K. Effects of propentofylline on hypoxia-hypoglycemia-induced calcium accumulation in gerbil hippocampal slices. J. Cereb. Blood Flow Metab. 1992; 12: 301-5.
26. Mitani A, Oomura Y, Yanase H, Kataoka K. Acidic fibroblast growth factor delays in vitro ischemia-induced intracellular calcium elevation in gerbil hippocampal slices: A sign of neuroprotection. Neurochem. Intern. 1992; 21: 337-41.
27. Takagi K, Endo K, Nagatsu Y. Studies on metabolic fate of 3-isobutyryl-2-isopropylpyrazolo [1,5-a] pyridine (KC-404). (I) Absorption, distribution and excretion in rats, dogs and monkeys. Oyo Yakuri 1985; 30: 967-81 (in Japanese with an English abstract).
28. Akaike N, Brown AM, Nishi K, Tsuda Y. Action of verapamil, diltiazem and other divalent cations on the calcium-current of Helix neurons. Br. J. Pharmacol 1981; 74: 87-95.
29. Docherty RJ, Brown DA. Interaction of 1,4-dihydropyridines with somatic Ca currents in hippocampal CA1 neurons of the guinea-pig in vitro. Neurosci. Lett. 1986; 70: 110-15.
30. Takahashi K, Akaike N. Calcium antagonist effects on low-threshold (T-type) calcium current in rat isolated hippocampal CA1 pyramidal neurons. J. Pharmacol. Exp. Ther. 1991; 256: 169-75.
31. 2+ in neurons. Neuroscience 1992; 46: 251-73.
32. Tsien RW, Tsien RY. Calcium channels, stores and oscillations. Annu. Rev. Cell Biol. 1990; 6: 715-60.
33. Hisayama T, Takayanagi I, Goromaru N, Okamoto Y. Potentiating effect of 3-isobutyryl-2-isopropylpyrazolo-[1,5a]-pyridine (KC-404), a new cerebral vasodilator with anti-platelet activity, on prostacyclin-induced increase of cyclic AMP content in platelets of rat. Gen. Pharmacol. 1989; 20: 183-6.
34. Bruns RF, Pons F, Daly JW. Glutamate- and veratridine-elicited accumulations of cyclic AMP in brain slices: A role for factors which potentiate adenosine-responsive systems. Brain Res. 1980; 189: 550-5.
35. Ferrendelli JA, Chang MM, Kinscherf DA. Elevation of cyclic GMP levels in central nervous system by excitatory amino acids. J. Neurochem. 1974; 22: 535-40.
36. Huang M, Gruenstein E, Daly JW. Depolarization-evoked accumulation of cyclic AMP in brain slices: Inhibition by exogenous adenosine deaminase. Biochem. Biophys. Acta 1973; 329: 147-51.
37. Mah HD, Daly JW. Adenosine-dependent formation of cyclic AMP in brain slices. Pharmacol. Res. Commun. 1976; 8: 65-79.
38. Shimizu H, Ichishita H, Odagiri H. Stimulated formation of cyclic adenosine 3′,5′-monophosphate by aspartate and glutamate in cerebral cortical slices of guinea-pig. J. Biol. Chem. 1974; 249: 5955-62.
39. 2+-mobilization and phospholipases in thrombin-stimulated human platelets. Biochem. Biophys. Res. Commun. 1983; 112; 693-700.
40. Yada Y, Nagao S, Okano Y, Nozawa Y. Inhibition by cyclic AMP of guanine nucleotide-induced activation of phosphoinositide-specific phospholipase C in human platelets. FEBS Lett. 1989; 242: 368-72.
41. Supattapone S, Danoff SK, Theibert A, Joseph SK, Steiner J, Snyder SH. Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc. Natl Acad. Sci. USA 1988; 85: 8747-50.
42. Bhalla RC, Webb RC, Singh D, Brock T. Role of cyclic AMP in rat aortic microsomal phosphorylation and calcium uptake. Am. J. Physiol. 1978; 234: 508-14.
43. Mickelson JR, Beaudry TM, Louis CF. Regulation of skeletal muscle sarcolemmal ATP-dependent calcium transport by calmodulin and cAMP-dependent protein kinase. Arch. Biochem. Biophys. 1985; 242: 127-36.
44. Aizawa T, Hasegawa T, Ohtomo E et al. Clinical evaluation of KC-404 in the treatment of cerebrovascular disorders. Clin. Eval. 1986; 14: 343-72 (in Japanese with an English abstract).
45. Funahashi K, Kuwata T, Naka D, Ogura M, Komai N. Clinacal Study of KETAS on mental dysfunctions accompanied with cerebrovascular disorders: Assessment of the effect on P300 and neuropsychological tests. Ageing Dis. 1993; 6: 97-108 (in Japanese with an English abstract).